AI Terminal
BSF ENTERPRISE PLC
Report Publication Announcement • Mar 14, 2024
5346_rns_2024-03-14_f27a0563-7006-4d3b-88fa-e1ef41300d19.html
Report Publication Announcement
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information 
RNS Number : 8416G
BSF Enterprise PLC
14 March 2024
14 March 2024
BSF Enterprise PLC
("BSF" or the "Company")
BSF Investor Evening
BSF Enterprise would like to welcome current shareholders and interested investors to an Investor Evening organised by Shard Capital Partners LLP on Tuesday, 19 March 2024.
At the event, a presentation will be delivered by the management of BSF Enterprise, followed by a Q&A session.
Hospitality will be provided.
The event will take place at 1790 Bar, St Swithin's Lane, London from 17.30
To register your interest in attending, please use the following link: https://forms.gle/FEmtcZT4mAA1DzS99
********************************************
Notes to Editors
About BSF Enterprise PLC:
BSF Enterprise PLC (BSF) is focused on unlocking the next generation of biotechnological solutions - using cell-based tissue engineering to help generate cultured meat, lab-grown leather, as well as human corneas, collagen growth and skin substitutes, as part of a radical transformation to deliver sustainable solutions across a variety of sectors.
It owns 100% of 3D Bio-Tissues (3DBT), a tissue engineering with patent-protected IP that is already producing human corneas for testing to help restore vision to millions of people. Building on this success, it aims to produce the UK's first high quality leather from its laboratory in Newcastle, transforming the leather industry towards an ethical and sustainable practice.
BSF aims to deliver growth to shareholders through the continued commercialisation of 3DBT's IP, which has multiple applications, as well as through M&A. It aims to develop a suite of technologies that underpins the development of tissue templating for corneas, meat and leather, and license out the IP to manufacturers, wholesalers and distributors to help manufacture the products at scale.
| -------------------------------------------------------------------- BSF Enterprise PLC |
Via SEC Newgate below |
| Geoff Baker - Executive Director Che Connon - CEO & Director |
|
| Shard Capital (Broker) | |
| Damon Heath Isabella Pierre |
0207 186 9000 0207 186 9927 |
| SEC Newgate (Financial Communications) | |
| Bob Huxford Elisabeth Cowell |
020 3757 6882 [email protected] |
ISIN of the Ordinary Shares is GB00BHNBDQ51
SEDOL Code is BHNBDQ5.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
MSCFIFFRVEISLIS